Related Experiment Video
Updated: Mar 17, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
14.0K
[Prostate cancer microenvironment: Its structure, functions and therapeutic applications].
Summary
The prostate tumor microenvironment, comprising immune cells and vasculature, significantly influences cancer progression. Emerging therapies targeting this ecosystem, like antiangiogenic treatments and immunotherapy, show promise but require further investigation.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- The tumor microenvironment (TME) is increasingly recognized as a critical factor in prostate cancer development and progression.
- Understanding the TME's structure and function is essential for developing effective cancer therapies.
Purpose of the Study:
- To describe the structure and functions of the prostate cancer microenvironment.
- To outline principal treatments targeting the prostate cancer microenvironment.
Main Methods:
- A systematic literature search was conducted on PubMed and ScienceDirect.
- Keywords included "tumour microenvironment," "neoplasm therapy," "microenvironnement tumoral," and "traitements."
- 50 articles were included from an initial pool of 593.
Main Results:
- The TME consists of host elements, including immune cells, support tissues, and neovascularization (vascular and lymphatic), that promote tumor growth.
- The TME plays a major role in prostate cancer, leading to the development of targeted treatments such as antiangiogenic therapy and immunotherapy.
Conclusions:
- The TME, tumor, and host are in constant mutual influence, creating a dynamic biological situation.
- Enhanced understanding of the prostate cancer TME facilitates a shift from tumor-centric to ecosystem-focused approaches.
- New TME-targeted treatments are emerging, but their optimal role in the therapeutic arsenal needs further definition.
Related Concept Videos
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.0K
3.0K
Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K

